News Search Results
Dec 21, 2023, 06:45 ET Mallinckrodt Announces Journal Publication of Economic Evidence for TERLIVAZ® (terlipressin) for Injection in Adults with Hepatorenal Syndrome (HRS)
segment's areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics; cultured skin substitutes and gastrointestinal products.
More news about: Mallinckrodt plc
Dec 20, 2023, 10:30 ET Global Photomedicine Market Size Projected to Reach USD 9,682.15 Million By 2032, With 7.3% CAGR: Polaris Market Research
encourage notable growth in this segment, announcing a metamorphic era in contemporary healthcare. Ophthalmology Segment Dominated the Market Based on application, the ophthalmology segment dominated the market. This is principally propelled by technological inventions. Photomedicine market
More news about: Polaris Market Research
Dec 20, 2023, 07:00 ET HanAll Biopharma, Daewoong Pharmaceutical and NurrOn Pharmaceuticals to Showcase Ongoing Parkinson's Disease Program at the 7th Annual Sachs Associates Neuroscience Innovation Forum
of endocrine, circulatory, and urologic diseases for 50 years. HanAll has also expanded its focus to immunology, oncology, neurology, and ophthalmology to discover and develop innovative medicines for patients with diseases for which there are no effective treatments. Its lead pipeline asset, HL161
More news about: HanAll Biopharma
Dec 18, 2023, 19:00 ET Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Granted Taletrectinib (ROS1 Inhibitor) Priority Review Designation
biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, and AnHeart Therapeutics ("AnHeart"), a global clinical-stage biopharmaceutical company developing novel precision therapies
More news about: Innovent Biologics
Dec 18, 2023, 16:16 ET PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND
(formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and PPL, has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a
More news about: Piramal Pharma Solutions
Dec 18, 2023, 16:10 ET PIRAMAL PHARMA SOLUTIONS COMMEMORATES OPENING OF ITS ADC MANUFACTURING EXPANSION IN GRANGEMOUTH, SCOTLAND
(formerly Allergan India Pvt Ltd), a joint venture between Allergan (now part of AbbVie) and PPL, has emerged as one of the market leaders in the ophthalmology therapy area. Further, PPL has a minority investment in Yapan Bio Private Limited. In October 2020, PPL received a
More news about: Piramal Pharma Solutions
Dec 17, 2023, 19:00 ET Innovent Announces Publication of Mazdutide (IBI362) Phase 2 Full Results in Chinese Patients with Overweight or Obesity in Nature Communications
biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that results of a Phase 2 clinical trial of mazdutide (Innovent R&D code: IBI362), a glucagon-like peptide-1
More news about: Innovent Biologics
Dec 15, 2023, 14:11 ET Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
needs to improve patients' lives is the cornerstone of this acquisition," says Euan S. Thomson, Ph.D., Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. "By joining forces with Dutch Ophthalmic Research Center,
More news about: Carl Zeiss Meditec AG
Dec 15, 2023, 13:58 ET Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
needs to improve patients' lives is the cornerstone of this acquisition," says Euan S. Thomson, Ph.D., Head of the Ophthalmology Strategic Business Unit and Head of the Digital Business Unit for ZEISS Medical Technology. "By joining forces with Dutch Ophthalmic Research Center,
More news about: Carl Zeiss Meditec AG
Dec 14, 2023, 22:35 ET Sjogrens Syndrome Therapeutics Market report from 2022-2027 by Technavio - The market size to grow by USD 691.09 million during the forecast period
Ophthalmology Therapeutics Market: The global ophthalmology therapeutics market size is estimated to grow by USD 18.15 billion at a CAGR of 6.78% between
More news about: Technavio
Dec 14, 2023, 10:01 ET Intraocular Lens Market Worth $6.0 billion | MarketsandMarkets
share in the end user segment of the intraocular lens market In End user segment, intraocular lens market is segmented into Hospitals, Ophthalmology Clinics, Eye Research Institutes, and Others. Hospital segments hold the highest market share in intraocular lens market. Factors such as large
More news about: MarketsandMarkets
Dec 13, 2023, 17:00 ET The Surgery Center of Rhode Island is Designated a "Top Ambulatory Surgery Center" by The Leapfrog Group for Clinical Quality and Patient Safety
specialize in ear, nose, throat, and ophthalmology surgeries. "It's such a privilege to work with the amazing team at SCRI. It's a testament to their unparalleled commitment to excellence in healthcare," said Phillip Rizzuto, MD- Co-Medical Director- Ophthalmology. Patients, employers, insurance
More news about: Constitution Surgery Alliance
Dec 13, 2023, 07:00 ET Jean-Claude Dubacher appointed to the Executive Board of B. Braun SE
commercial, supply chain, and manufacturing. Before joining B. Braun, he was Head of Commercial Operations for Johnson & Johnson's surgical ophthalmology division in Europe, the Middle East and Africa.
More news about: B. Braun Medical Inc.
Dec 13, 2023, 05:25 ET Disposable Contact Lenses Market worth $14.93 Bn by 2031 - Exclusive Report by InsightAce Analytic
Frequent/Planned/Extended Wear), Application (Corrective, Therapeutic, And Cosmetic Lenses), Distribution (Retail Optical Stores, Hospitals & Ophthalmology Clinics, And Online Stores), Design, Region, Market Outlook And Industry Analysis 2031"
More news about: InsightAce Analytic Pvt. Ltd
Dec 12, 2023, 23:51 ET Innovent Announces Inclusion in the China National Reimbursement Drug List of TYVYT® 's Seventh Indication and BYVASDA®'s Eighth Indication
biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and other major diseases, announces that, the National Reimbursement Drug List (2023 Version) ("NRDL") has been updated to renew and include the
More news about: Innovent Biologics
Dec 12, 2023, 09:30 ET Wilmington Community Rallies for first Dry Eye Fundraiser
than two decades, Dr. Brimer has spent her career advancing the science of diagnosing and treating dry eye disease. She has been featured in the Ophthalmology Times, Global Newswire and television. Brimer enjoys publishing articles and traveling, both nationally and internationally, to lecture and consult
More news about: Hope In Sight
Dec 12, 2023, 09:00 ET FundamentalVR Recognized as a Growth and Innovation Leader in Frost & Sullivan's Radar Report for Medical VR Training and Education
Surgery, the company stands out for scaling solutions across a broad spectrum of use cases and capabilities, including endovascular, robotics, ophthalmology, urology, orthopedics, and spine.
More news about: FundamentalVR
Dec 12, 2023, 07:19 ET BELKIN Vision Announces FDA Clearance for the Eagle™ Device
intended for use in performing selective laser trabeculoplasty (SLT). This milestone achievement marks a significant advancement in the field of ophthalmology, offering expanded treatment options for individuals suffering from glaucoma.
More news about: BELKIN Vision
Dec 12, 2023, 02:35 ET Gene therapy market size to grow by USD 4,613.9 million from 2022 to 2027 | North America is estimated to contribute 39% to the growth - Technavio
- Segmentation AssessmentSegment OverviewTechnavio has segmented the market based on therapy areas (oncology, CNS, ophthalmology, rare diseases, and others), and delivery mode (in vivo and ex vivo). The market growth in the oncology segment will be
More news about: Technavio
Dec 11, 2023, 17:01 ET AMSURG Announces Two Additions to Executive Team
health systems, the organization delivers high-quality patient care across a diverse spectrum of medical specialties, including gastroenterology, ophthalmology and orthopedics. With a focus on strategic growth and innovation, AMSURG is committed to transforming the future of ambulatory surgery center care
More news about: AMSURG
Dec 11, 2023, 14:30 ET IASO Bio and Innovent Present New Data of FUCASO® (Equecabtagene Autoleucel) for Multiple Myeloma Patients in Oral Presentation at ASH 2023
biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune, ophthalmology and other major diseases, today announced the latest analysis results from the FUMANBA-1 study of Equecabtagene Autoleucel for the treatment of
More news about: IASO Bio
Dec 11, 2023, 07:00 ET HanAll Biopharma's Partner, NurrOn Pharmaceuticals Incorporated Appoints Dr. Almira Chabi, MD, EGMP to Board of Directors
encompassing over 20 countries. Dr. Chabi began her pharmaceutical career at Merck in the Neuroscience & Ophthalmology Clinical Research Group, working on a range of projects within Ophthalmology as well as Neuroscience leading to multiple successful NDA filings. In addition to expertise in drug
More news about: HanAll Biopharma
Dec 11, 2023, 06:14 ET Cancer Biopsy Market Surpass $67.11 billion by 2030 - Exclusive Report by Coherent Market Insights
(General Outpatient Clinics, Cardiology Clinics, Orthopedic Clinics, Dermatology Clinics, Gynecology Clinics, Pediatric Clinics, Dental Clinics, Ophthalmology Clinics, Others), By Medical Services (Diagnosis and Treatment, Preventive Care, Rehabilitation Services, Wellness Programs, Laboratory Testing,
More news about: Coherent Market Insights
Dec 11, 2023, 02:00 ET Hoba Therapeutics raises EUR 23 million in a Series A to advance new drug candidate against chronic neuropathic pain
in the development of innovative pharmacological therapies, across all therapeutic indications but with particular attention to Oncology, CNS, Ophthalmology, Metabolic diseases, Virology, and Infectious diseases. Indaco is focused on the Italian Biotech sector with select investments in other European
More news about: Hoba Therapeutics
Dec 08, 2023, 17:15 ET United States Ambulatory Surgical Centers Market Report 2023-2028: Healthcare Providers Eye Inorganic Growth Strategies, Ownership Changes Fuel ASC Revolution
The number of people suffering from gastroenterology disorders are increasing in the US and will increase further.In 2019, the number of ophthalmology ASCs in the US was less than 100; in 2022, it has increased to more than 1,000. This segment is still growing faster in the market, and the number
More news about: Research and Markets